GlassScriptPhysician profile
Raj Grover
NPI 1811341852
$2,018.22
in general payments reported to CMS, 2019-2025
15 companies · $325 in 2025
The $325 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $11.94 · 2021: $282 · 2022: $272 · 2023: $538 · 2024: $590 · 2025: $325.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,453.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,452.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerecis Limited | $543.96 | 2021-2024 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Amgen INC. | $425.80 | 2021-2025 | Krystexxa, Evenity, Prolia |
| Organogenesis INC. | $212.71 | 2023-2024 | Puraply |
| Abbvie INC. | $153.77 | 2021-2024 | |
| Smith+Nephew, INC. | $132.80 | 2020-2022 | |
| Integra Lifesciences Corporation | $117.78 | 2021-2023 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Biocomposites INC | $109.08 | 2024 | |
| Orthofix Medical, INC. | $72.10 | 2024-2025 | Physio-Stim |
| Solventum Corporation | $59.85 | 2024 | Activ.A.C. |
| Advanced Oxygen Therapy INC. | $52.68 | 2021-2022 | |
| Sandoz INC. | $47.08 | 2023-2024 | Hyrimoz |
| Janssen Biotech, INC. | $33.18 | 2024 | Tremfya |
| Otsuka Pharmaceutical Development & Commercialization, INC. | $23.02 | 2024 | Rexulti |
| Exact Sciences Corporation | $19.37 | 2025 | Cologuard Collection Kit |
| Janssen Pharmaceuticals, INC | $15.04 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Raj Grover listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.